Functional and phenotypical activation of leucocytes in inflamed human colonic mucosa

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 12, 1997, Pages 809-814

  Oshitani, Nobuhide ^a   Sawa, Yoshinori ^a   Hara, Junichi ^a   Adachi, Kenji ^a   Nakamura, Shiro ^a   Matsumoto, Takayuki ^a   Arakawa, Tetsuo ^a   Kuroki, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Eosinophil; Macrophage; Reactive oxygen species; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MALE; MUCOSA INFLAMMATION; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031416542     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00376.x     Document Type: Article

References (24)

1. Mahida YR, Patel S, Gionchetti P et al. Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 1989; 30: 826-34.
2. Choy MY, Walker-Smith JA, Williams CB et al. Activated eosinophils in chronic inflammatory bowel disease. Lancet 1990; 336: 126-7.
3. Selby WS, Poulter LW, Hobbs S et al. Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J. Clin. Pathol. 1983; 36: 379-84.
4. Brandtzaeg P, Dale I, Gabrielsen T-Ø. The leukocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology 1992; 21: 191-6.
5. Bjerke K, Halstensen TS, Jahnsen F et al. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993; 34: 1357-63.
6. Oshitani N, Kitano A, Okabe H et al. Location of nitroblue tetrazolium-reducing activity in human colonie mucosa obtained by biopsy. Dig. Dis. Sci. 1993; 38: 546-50.
7. Oshitani N, Kitano A, Okabe H et al. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993; 34: 936-8.
8. Oshitani N, Campbell A, Bloom S et al. Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonie mucosa. Scand. J. Gastroenterol. 1995; 30: 915-20.
9. Matts SGF. The value of rectal biopsy in the diagnosis of UC. QJM 1961; 30: 393-407.
10. Lapenna D, Cuccurullo F. Location of superoxide anion in the human colonie mucosa. Gut 1994; 35: 284.
11. Dale I, Brandtzaeg P, Fagerhol MK et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am. J. Clin. Pathol. 1985; 84: 24-34.
12. Steinbakk M, Naess-Andresen CF, Lingaas E et al. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet 1990; 336: 763-5.
13. Sohnle PG, Collins-Lech C, Wiessner JH. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J. Infect. Dis. 1991; 163: 187-92.
14. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am. J. Clin. Pathol. 1987; 87: 681-99.
15. Zwadlo G, Brüggen J, Gerhards G et al. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol. 1988; 72: 510-15.
16. Hauptmann S, Zwadlo-Klarwasser G, Hartung P et al. Association of different macrophage phenotypes with infiltrating and non-infiltrating areas of tumor-host interface in colorectal carcinoma. Pathol. Res. Pract. 1994; 190: 159-67.
17. Rugtveit J, Brandtzaeg P, Halstensen TS et al. Increased macrophages subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35: 669-74.
18. Wright R, Truelove SC. Circulating and tissue eosinophils. Am. J. Dig. Dis. 1966; 11: 831-46.
19. Oshitani N, Campbell A, Kitano A et al. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J. Pathol. 1996; 178: 95-9.
20. Berstad A, Borkje B, Riedel B et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology 1993; 40: 276-8.
21. Yamasaki K, Makiyama K, Murata I et al. Evaluation of serum eosinophil cationic protein (ECP) level in patients with UC. Gastroenterol. Jpn. 1991; 26: 232.
22. Jahnsen FL, Brandtzaeg P, Halstensen TS. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J. Immunol. Methods 1994; 175: 23-6.
23. Walker C, Rihs S, Braun RK et al. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J. Immunol. 1993; 150: 4061-71.
24. Sedgwick JB, Calhoun WJ, Vrtis RF et al. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 1992; 149: 3710-18.